Whelan, B.-M.; Aldridge, D.; Ruhle, J.; Whitelock, P.; Taubert, S.; Collins, A.; Kearney, E.; Charania, S.; Henderson, R.D.; Wallace, S.J.;
et al. To Treat or Not to Treat: A Scoping Review of Speech Treatment for Dysarthria in Amyotrophic Lateral Sclerosis (ALS). Healthcare 2025, 13, 2434.
https://doi.org/10.3390/healthcare13192434
AMA Style
Whelan B-M, Aldridge D, Ruhle J, Whitelock P, Taubert S, Collins A, Kearney E, Charania S, Henderson RD, Wallace SJ,
et al. To Treat or Not to Treat: A Scoping Review of Speech Treatment for Dysarthria in Amyotrophic Lateral Sclerosis (ALS). Healthcare. 2025; 13(19):2434.
https://doi.org/10.3390/healthcare13192434
Chicago/Turabian Style
Whelan, Brooke-Mai, Danielle Aldridge, Jessica Ruhle, Persephone Whitelock, Shana Taubert, Annette Collins, Elaine Kearney, Salma Charania, Robert D. Henderson, Sarah J. Wallace,
and et al. 2025. "To Treat or Not to Treat: A Scoping Review of Speech Treatment for Dysarthria in Amyotrophic Lateral Sclerosis (ALS)" Healthcare 13, no. 19: 2434.
https://doi.org/10.3390/healthcare13192434
APA Style
Whelan, B.-M., Aldridge, D., Ruhle, J., Whitelock, P., Taubert, S., Collins, A., Kearney, E., Charania, S., Henderson, R. D., Wallace, S. J., Mitchell, C., Stipancic, K. L., Kuruvilla-Dugdale, M., & Vogel, A. P.
(2025). To Treat or Not to Treat: A Scoping Review of Speech Treatment for Dysarthria in Amyotrophic Lateral Sclerosis (ALS). Healthcare, 13(19), 2434.
https://doi.org/10.3390/healthcare13192434
